📰 Trials Unit News
Page 4 - Trials Unit News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trials Unit. Real-time updates on events, politics, business and more.
January 27, 2023
Carlos del Rio, an internationally known clinician and epidemiologist, has been named interim dean for Emory School of Medicine. He will begin his appointment on March 1.
December 7, 2022
A new study proposes a novel strategy to treat type 2 diabetes, putting individuals in command of their own medicine
October 26, 2022
Two researchers at the University of Guelph have been given the green light to grow mushrooms known to produce psilocybin
October 25, 2022
/PRNewswire/ -- The global prostate cancer therapeutics market size is expected to reach USD 21.5 billion by 2030, according to a new report by Grand View...
September 18, 2022
Drinking four cups of tea a day was linked to a 17% lower risk for developing type 2 diabetes in a study, but experts warn these data are observational and far from conclusive.
September 17, 2022
UW Medicine researchers are recruiting participants for a Phase 3 clinical trial of a drug to treat the monkeypox virus.
September 9, 2022
Liz will reflect on a career, both as a statistician and a teacher, which has taken her from London secondary school maths classrooms, through working on UK-based clinical trials, to collaborating on pragmatic trials of health interventions in varied and sometimes challenging settings.
July 27, 2022
Psychedelics arent just for experimenting teenagers and mystic shamans anymore, as controlled drugs that were once considered dangerous and of no ...
July 27, 2022
Can the compound found in magic mushrooms help treat depression without making people high?
May 26, 2022
In this talk, Professor Dunn will discuss the analysis of active-control trials with a time-to-event outcome. He will show that the standard metric used in such trials, the rate ratio or rate difference comparing experimental and control arms, may not be the most clinically relevant measure. An alternative measure will be proposed, which requires specification of one of two unobserved parameters. The problem will be exemplified by studies from HIV pre-exposure prophylaxis, TB preventative tr...